StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
480
This month
35
This week
2
This year
205
Publishing Date
2022 - 06 - 17
5
2022 - 06 - 14
3
2022 - 06 - 10
3
2022 - 06 - 02
3
2022 - 06 - 01
5
2022 - 05 - 27
4
2022 - 05 - 24
3
2022 - 05 - 23
3
2022 - 05 - 16
5
2022 - 05 - 14
3
2022 - 05 - 12
5
2022 - 05 - 11
4
2022 - 05 - 03
4
2022 - 04 - 29
3
2022 - 04 - 28
8
2022 - 04 - 26
3
2022 - 04 - 21
3
2022 - 04 - 20
4
2022 - 04 - 14
3
2022 - 04 - 13
6
2022 - 04 - 12
5
2022 - 04 - 08
4
2022 - 03 - 16
4
2022 - 03 - 11
3
2022 - 03 - 10
4
2022 - 03 - 08
4
2022 - 03 - 01
5
2022 - 02 - 18
3
2022 - 02 - 17
4
2022 - 01 - 05
3
2021 - 12 - 14
4
2021 - 12 - 13
3
2021 - 12 - 06
3
2021 - 11 - 15
3
2021 - 11 - 04
4
2021 - 11 - 01
4
2021 - 10 - 29
4
2021 - 10 - 07
3
2021 - 09 - 16
4
2021 - 09 - 03
3
2021 - 08 - 18
3
2021 - 08 - 11
3
2021 - 08 - 09
3
2021 - 07 - 29
3
2021 - 07 - 23
3
2021 - 07 - 08
4
2021 - 06 - 29
3
2021 - 06 - 11
4
2021 - 06 - 09
5
2021 - 06 - 04
5
2021 - 06 - 03
3
2021 - 05 - 24
5
2021 - 05 - 12
3
2021 - 05 - 10
3
2021 - 04 - 23
3
2021 - 04 - 07
4
2021 - 04 - 05
3
2021 - 04 - 02
3
2021 - 03 - 18
3
2020 - 12 - 02
2
Sector
Commercial services
2
Communications
6
Consumer durables
1
Consumer non-durables
1
Consumer services
1
Electronic technology
8
Energy minerals
3
Finance
6
Finance and insurance
3
Health services
3
Health technology
480
Industrial services
2
Information
1
Manufacturing
45
Mining, quarrying, and oil and gas extraction
1
Miscellaneous
1
N/a
2
Non-energy minerals
1
Process industries
3
Producer manufacturing
3
Retail trade
2
Technology services
7
Utilities
2
Tags
Acquisition
7
Aesthetic
13
Alliances
12
America
5
Antiviral
5
Application
9
Approval
30
Atopic dermatitis
10
Biomidwest
30
Bioscience
9
Biosimilar
6
Biotech-beach
6
Cancer
25
Ces
7
Chmp
6
Clinical-trials-phase-iii
19
Collaboration
13
Conference
15
Contract
8
Covid
6
Deadline
36
Dermatitis
10
Designation
5
Device
7
Disease
35
Drug
50
Earnings
13
Ema
6
Europe
12
Ev
7
Events
13
Eye
9
Fda
30
Fda approval
8
Financial results
12
Food
5
For
19
Granted
6
Growing
7
Growth
43
Health
9
Humira
5
Leukemia
12
Lung cancer
6
Market
41
Migraine
11
N/a
324
Pharma
8
Phase 3
26
Positive
20
Report
22
Research
31
Results
42
Rinvoq
12
Risankizumab
12
Skyrizi
6
Therapeutics
20
Therapy
24
Treatment
60
Trial
18
Entities
Abbott laboratories
11
Abbvie inc.
480
Adc therapeutics sa
5
Agios pharmaceuticals, inc.
12
Alexion pharmaceuticals, inc.
16
Alkermes plc
6
Alnylam pharmaceuticals, inc.
10
Amgen inc.
64
Astellas pharma inc
14
Astrazeneca plc
29
Aveo pharmaceuticals, inc.
10
Bausch health companies inc.
25
Baxter international inc.
8
Becton, dickinson and company
4
Beigene, ltd.
11
Biocryst pharmaceuticals, inc.
13
Biogen inc.
8
Biomarin pharmaceutical inc.
4
Blueprint medicines corporation
10
Boston scientific corporation
4
Bristol-myers squibb company
42
Catalent, inc.
4
Clovis oncology, inc.
10
Coherus biosciences, inc.
32
Cti biopharma corp.
4
Eli lilly and company
54
Epizyme, inc.
10
Establishment labs holdings inc.
3
Exelixis, inc.
10
Genmab a/s
10
Gilead sciences, inc.
20
Glaxosmithkline plc
48
I-mab
3
Illumina, inc.
10
Incyte corporation
11
Ironwood pharmaceuticals, inc.
7
Jabil inc.
4
Johnson & johnson
58
Karyopharm therapeutics inc.
12
Medtronic plc
8
Mylan n.v.
8
Neos therapeutics, inc.
13
Novartis ag
66
Novo nordisk a/s
7
Omeros corporation
13
Orange
4
Otonomy, inc.
13
Pfizer, inc.
29
Regeneron pharmaceuticals, inc.
19
Rigel pharmaceuticals, inc.
10
Sanofi
74
Soliton, inc.
5
Takeda pharmaceutical company limited
13
Teva pharmaceutical industries limited
4
Teva pharmaceutical industries ltd
19
Thermo fisher scientific inc
12
Verastem, inc.
10
Viatris inc.
8
Xeris pharmaceuticals, inc.
10
Y-mabs therapeutics, inc.
10
Symbols
AAPL
483
ABB
610
ABBV
480
ABLZF
351
ABT
686
AMGN
342
APO
271
ARVL
1730
AZN
298
BDX
402
BMY
354
BNPQF
549
BNPQY
549
BNPZY
548
BSX
296
CNY
435
CSCO
434
DHR
343
DOW
287
ERIC
732
EXTR
321
F
267
FNCTF
2055
FRBA
316
GE
460
GOOG
324
GOOGL
327
GSK
407
HON
732
HUBS
997
IBM
330
INR
438
INTC
411
JNJ
2200
LLY
863
LYV
309
MDT
593
MLPY
436
MMM
449
MS
2099
MSFT
600
NOK
283
NVO
295
NVS
489
NVSEF
287
OCX
269
ORCL
555
PFE
373
PHG
457
PPRUF
376
PPRUY
377
SAP
666
SAPGF
401
SNOW
338
SNY
1881
SNYNF
931
TMO
629
TOT
719
URR
434
VZ
445
Exchanges
Lse
26
Nasdaq
219
Nyse
480
Tsx
12
Crawled Date
2022 - 06 - 17
5
2022 - 06 - 14
3
2022 - 06 - 10
3
2022 - 06 - 02
3
2022 - 06 - 01
5
2022 - 05 - 27
4
2022 - 05 - 24
3
2022 - 05 - 23
3
2022 - 05 - 16
5
2022 - 05 - 14
3
2022 - 05 - 12
5
2022 - 05 - 11
4
2022 - 05 - 03
4
2022 - 04 - 29
3
2022 - 04 - 28
8
2022 - 04 - 26
3
2022 - 04 - 21
3
2022 - 04 - 20
4
2022 - 04 - 14
3
2022 - 04 - 13
6
2022 - 04 - 12
5
2022 - 04 - 08
5
2022 - 03 - 16
4
2022 - 03 - 11
3
2022 - 03 - 10
3
2022 - 03 - 08
4
2022 - 03 - 01
4
2022 - 02 - 18
3
2022 - 02 - 17
4
2022 - 01 - 05
3
2021 - 12 - 14
3
2021 - 12 - 13
3
2021 - 12 - 06
3
2021 - 11 - 15
3
2021 - 11 - 05
3
2021 - 11 - 04
3
2021 - 11 - 01
4
2021 - 10 - 29
4
2021 - 10 - 07
3
2021 - 09 - 16
4
2021 - 09 - 03
3
2021 - 08 - 18
3
2021 - 08 - 11
3
2021 - 08 - 09
3
2021 - 07 - 29
3
2021 - 07 - 27
3
2021 - 07 - 08
4
2021 - 06 - 29
3
2021 - 06 - 11
4
2021 - 06 - 09
5
2021 - 06 - 04
5
2021 - 06 - 03
3
2021 - 05 - 24
4
2021 - 05 - 12
3
2021 - 05 - 10
3
2021 - 04 - 23
3
2021 - 04 - 07
4
2021 - 04 - 05
3
2021 - 04 - 02
3
2020 - 12 - 02
2
Crawled Time
00:00
8
00:20
1
01:00
12
01:10
1
02:00
7
03:00
9
04:00
4
04:20
2
05:00
2
06:00
12
07:00
9
08:00
8
09:00
2
10:00
26
10:10
1
10:51
1
11:00
16
12:00
22
12:15
10
12:20
5
12:30
3
12:34
1
13:00
29
13:07
3
13:13
1
13:15
10
13:17
1
13:20
3
13:27
1
13:30
10
13:50
1
14:00
33
14:03
1
14:04
1
14:07
1
14:12
1
14:15
7
14:20
2
14:30
7
15:00
25
15:11
1
15:15
7
15:20
5
15:30
6
15:49
1
16:00
28
16:20
3
17:00
19
17:37
1
17:43
1
18:00
16
18:04
1
18:26
1
18:31
2
19:00
18
20:00
18
20:20
3
21:00
12
22:00
18
23:00
14
Source
beamforall.com
1
investor.assemblybio.com
2
www.biospace.com
156
www.fda.gov
24
www.globenewswire.com
37
www.prnewswire.com
259
www.vermillion.com
1
Sort by:
after hours percent change
|
delayed percent change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
Abbv
save search
MSP Recovery Commences Billing Big Pharma More Than $5.6 Billion In Billed Amounts and More Than $2.8 Billion In Paid Amounts
Published:
2022-06-28
(Crawled : 02:00)
- globenewswire.com
ABBV
|
$154.14
1.08%
-1.03%
|
|
Health Technology
|
0.7%
|
O:
0.06%
H:
1.27%
C:
-0.44%
LLY
|
News
S
|
$323.0
1.69%
0.07%
|
|
Health Technology
|
-0.19%
|
O:
0.99%
H:
0.0%
C:
0.0%
SNY
|
News
|
$52.67
1.02%
-0.32%
|
|
Health Technology
|
-0.08%
|
O:
-0.27%
H:
0.0%
C:
0.0%
pharma
CHMP Recommends Approval of Upadacitinib (RINVOQ®) for the Treatment of Adults with Active Non-Radiographic Axial Spondyloarthritis
Published:
2022-06-27
(Crawled : 07:00)
- prnewswire.com
ABBV
|
$154.14
1.08%
-1.03%
|
|
Health Technology
|
2.26%
|
O:
1.55%
H:
0.0%
C:
0.0%
rinvoq
treatment
active
for
chmp
approval
Irritable Bowel Syndrome Treatment Market to Surpass US$ 3,902.9 Million by 2030 - Coherent Market Insights
Published:
2022-06-24
(Crawled : 18:00)
- prnewswire.com
ALPMY
|
News
|
$15.75
-2.42%
|
|
Manufacturing
|
-1.07%
|
O:
4.33%
H:
0.0%
C:
-2.44%
ALPMF
|
News
|
$16.71
5.56%
|
|
Health Technology
|
6.07%
|
O:
0.99%
H:
0.0%
C:
-0.5%
ABBV
|
$154.14
1.08%
-1.03%
|
|
Health Technology
|
3.86%
|
O:
1.57%
H:
0.0%
C:
0.0%
BHC
|
News
A
|
$8.51
-3.62%
0.0%
|
|
Health Technology
|
17.06%
|
O:
5.78%
H:
13.91%
C:
13.78%
IRWD
|
$11.72
1.65%
1.45%
|
|
Health Technology
|
6.06%
|
O:
0.27%
H:
2.08%
C:
1.99%
TAK
|
$13.85
-0.07%
0.0%
|
|
Health Technology
|
0.87%
|
O:
0.36%
H:
0.0%
C:
0.0%
NVS
|
News
|
$84.77
0.71%
-0.64%
|
|
Health Technology
|
3.9%
|
O:
2.38%
H:
0.0%
C:
0.0%
treatment
market
Rheumatoid Arthritis Drugs Market Size to Grow by USD 14.90 Billion | 37% of the growth will originate from Europe | Technavio
Published:
2022-06-24
(Crawled : 09:00)
- prnewswire.com
ALPMY
|
News
|
$15.75
-2.42%
|
|
Manufacturing
|
-1.07%
|
O:
4.33%
H:
0.0%
C:
-2.44%
SNY
|
News
|
$52.67
1.02%
-0.32%
|
|
Health Technology
|
3.97%
|
O:
3.49%
H:
0.0%
C:
0.0%
ALPMF
|
News
|
$16.71
5.56%
|
|
Health Technology
|
6.07%
|
O:
0.99%
H:
0.0%
C:
-0.5%
ABBV
|
$154.14
1.08%
-1.03%
|
|
Health Technology
|
3.86%
|
O:
1.57%
H:
0.0%
C:
0.0%
GLAXF
|
News
|
$21.01
-4.46%
|
|
Health Technology
|
0.89%
|
O:
3.19%
H:
2.28%
C:
-1.81%
AMGN
|
$245.43
0.79%
0.0%
|
|
Health Technology
|
1.51%
|
O:
0.92%
H:
0.82%
C:
0.56%
GSK
|
News
|
$43.77
0.97%
-0.87%
|
|
Health Technology
|
2.92%
|
O:
1.79%
H:
0.95%
C:
0.92%
NVS
|
News
|
$84.77
0.71%
-0.64%
|
|
Health Technology
|
3.9%
|
O:
2.38%
H:
0.0%
C:
0.0%
GLMD
|
$0.65
10.02%
-3.85%
|
|
Health Technology
|
31.58%
|
O:
1.21%
H:
0.0%
C:
-3.5%
europe
growth
market
AbbVie Declares Quarterly Dividend
Published:
2022-06-23
(Crawled : 20:00)
- prnewswire.com
ABBV
|
$154.14
1.08%
-1.03%
|
|
Health Technology
|
3.86%
|
O:
1.57%
H:
0.0%
C:
0.0%
Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market to Surpass US$ 20,450.6 Million by 2030 - Coherent Market Insights
Published:
2022-06-22
(Crawled : 19:00)
- prnewswire.com
ABBV
|
$154.14
1.08%
-1.03%
|
|
Health Technology
|
4.46%
|
O:
0.57%
H:
0.0%
C:
0.0%
GSK
|
News
|
$43.77
0.97%
-0.87%
|
|
Health Technology
|
4.19%
|
O:
1.24%
H:
0.0%
C:
0.0%
ENDP
|
$0.5226
-26.39%
0.56%
|
|
Health Technology
|
45.17%
|
O:
-2.25%
H:
13.16%
C:
10.83%
GLAXF
|
News
|
$21.01
-4.46%
|
|
Health Technology
|
-2.23%
|
O:
-0.14%
H:
0.14%
C:
-2.96%
PFE
|
News
|
$50.94
0.55%
-0.43%
|
|
Health Technology
|
3.81%
|
O:
0.43%
H:
0.0%
C:
0.0%
infections
skin
market
AbbVie Seeks New Indication for Migraine Drug Qulipta, Drops Deal with Morphic
Published:
2022-06-22
(Crawled : 16:00)
- biospace.com/
ABBV
|
$154.14
1.08%
-1.03%
|
|
Health Technology
|
10.17%
|
O:
2.73%
H:
4.44%
C:
2.67%
drug
for
deal
migraine
AbbVie Submits Supplemental New Drug Application to U.S. FDA for Atogepant (QULIPTA™) to Support Label Expansion for the Preventive Treatment of Migraine
Published:
2022-06-21
(Crawled : 14:00)
- biospace.com/
ABBV
|
$154.14
1.08%
-1.03%
|
|
Health Technology
|
11.8%
|
O:
1.48%
H:
0.0%
C:
0.0%
treatment
fda
expansion
drug
label
for
application
migraine
AbbVie's Skyrizi Becomes First FDA-Approved IL-23 Inhibitor for Crohn's Disease
Published:
2022-06-20
(Crawled : 12:20)
- biospace.com/
ABBV
|
$154.14
1.08%
-1.03%
|
|
Health Technology
|
Email alert
Add to watchlist
il-23
skyrizi
disease
for
Outlook on the Antidepressant Drugs Global Market to 2030 - Featuring Alkermes, AbbVie and GlaxoSmithKline Among Others
Published:
2022-06-17
(Crawled : 19:00)
- prnewswire.com
ABBV
|
$154.14
1.08%
-1.03%
|
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
News
|
$7.575
-9.17%
|
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
S
|
$323.0
1.69%
0.07%
|
|
Health Technology
|
Email alert
Add to watchlist
ALKS
|
$30.29
-0.33%
0.0%
|
|
Health Technology
|
Email alert
Add to watchlist
market
Biologic Therapy Market Information: By Product and Geography - Global Forecast till 2025
Published:
2022-06-17
(Crawled : 14:00)
- prnewswire.com
AZNCF
|
$131.0
-0.53%
|
|
Health Technology
|
10.32%
|
O:
1.89%
H:
0.0%
C:
-0.64%
NVS
|
News
|
$84.77
0.71%
-0.64%
|
|
Health Technology
|
4.1%
|
O:
0.07%
H:
0.0%
C:
0.0%
GSK
|
News
|
$43.77
0.97%
-0.87%
|
|
Health Technology
|
5.5%
|
O:
-0.24%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$84.85
1.0%
|
|
Health Technology
|
4.91%
|
O:
0.74%
H:
0.52%
C:
-3.23%
GLAXF
|
News
|
$21.01
-4.46%
|
|
Health Technology
|
2.05%
|
O:
0.01%
H:
0.17%
C:
0.17%
ABBV
|
$154.14
1.08%
-1.03%
|
|
Health Technology
|
12.97%
|
O:
1.05%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$108.84
4.15%
|
|
Health Technology
|
12.02%
|
O:
-1.76%
H:
5.75%
C:
5.5%
JNJ
|
News
|
$176.99
0.03%
-0.29%
|
|
Health Technology
|
5.33%
|
O:
1.35%
H:
0.0%
C:
0.0%
SNY
|
News
|
$52.67
1.02%
-0.32%
|
|
Health Technology
|
8.43%
|
O:
1.39%
H:
0.0%
C:
0.0%
AZN
|
$67.02
1.65%
-0.48%
|
|
Health Technology
|
10.14%
|
O:
0.59%
H:
0.0%
C:
0.0%
therapy
market
Global Conjugated Monoclonal Antibodies (mAbs) Market Report 2022: A $12.09 Billion Market by 2026 - Forecast to 2031
Published:
2022-06-17
(Crawled : 13:20)
- prnewswire.com
ABBV
|
$154.14
1.08%
-1.03%
|
|
Health Technology
|
12.97%
|
O:
1.05%
H:
0.0%
C:
0.0%
NVS
|
News
|
$84.77
0.71%
-0.64%
|
|
Health Technology
|
4.1%
|
O:
0.07%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$84.85
1.0%
|
|
Health Technology
|
4.91%
|
O:
0.74%
H:
0.52%
C:
-3.23%
report
market
SKYRIZI® (risankizumab-rzaa) Receives FDA Approval as the First and Only Specific Interleukin-23 (IL-23) to Treat Moderately to Severely Active Crohn's Disease in Adults
Published:
2022-06-17
(Crawled : 12:20)
- prnewswire.com
ABBV
|
$154.14
1.08%
-1.03%
|
|
Health Technology
|
12.97%
|
O:
1.05%
H:
0.0%
C:
0.0%
il-23
skyrizi
fda
disease
active
approval
Global Targeted Drug Delivery Market 2022-2030 with 2021 as the Base Year
Published:
2022-06-17
(Crawled : 12:00)
- prnewswire.com
AZNCF
|
$131.0
-0.53%
|
|
Health Technology
|
10.32%
|
O:
1.89%
H:
0.0%
C:
-0.64%
SNYNF
|
News
|
$108.84
4.15%
|
|
Health Technology
|
12.02%
|
O:
-1.76%
H:
5.75%
C:
5.5%
BSX
|
News
S
|
$37.8
0.8%
0.0%
|
|
Health Technology
|
8.0%
|
O:
1.69%
H:
2.14%
C:
1.18%
BAX
|
$65.81
0.86%
0.0%
|
|
Health Technology
|
-1.17%
|
O:
-1.77%
H:
0.0%
C:
0.0%
ABBV
|
$154.14
1.08%
-1.03%
|
|
Health Technology
|
12.97%
|
O:
1.05%
H:
0.0%
C:
0.0%
ARWR
|
$34.56
6.44%
0.0%
|
|
Health Technology
|
22.64%
|
O:
0.67%
H:
7.55%
C:
2.64%
SNY
|
News
|
$52.67
1.02%
-0.32%
|
|
Health Technology
|
8.43%
|
O:
1.39%
H:
0.0%
C:
0.0%
AZN
|
$67.02
1.65%
-0.48%
|
|
Health Technology
|
10.14%
|
O:
0.59%
H:
0.0%
C:
0.0%
drug
year
market
Facial Aesthetics Market: USD 1.45 billion Growth from 2020 to 2025 | High Competition in the Market due to the Presence of Region-specific Vendors| Technavio
Published:
2022-06-14
(Crawled : 15:20)
- prnewswire.com
BHC
|
News
A
|
$8.51
-3.62%
0.0%
|
|
Health Technology
|
12.27%
|
O:
-0.26%
H:
0.73%
C:
-2.12%
ABBV
|
$154.14
1.08%
-1.03%
|
|
Health Technology
|
9.4%
|
O:
-1.04%
H:
0.87%
C:
-1.31%
ANIK
|
$22.51
1.44%
0.0%
|
|
Health Technology
|
10.02%
|
O:
0.2%
H:
0.54%
C:
-0.1%
growth
market
Global Axial Spondyloarthritis Market Research Repoirt 2022: Biopharmaceutical Companies are Trying to Match Themselves with New Technologies in the Market to Improve the Overall System
Published:
2022-06-14
(Crawled : 11:00)
- prnewswire.com
ABBV
|
$154.14
1.08%
-1.03%
|
|
Health Technology
|
9.4%
|
O:
-1.04%
H:
0.87%
C:
-1.31%
JNJ
|
News
|
$176.99
0.03%
-0.29%
|
|
Health Technology
|
4.09%
|
O:
0.43%
H:
0.0%
C:
0.0%
BMY
|
$78.28
-0.53%
-1.0%
|
|
Health Technology
|
6.02%
|
O:
-0.4%
H:
0.33%
C:
-0.91%
UCBJY
|
$43.05
0.78%
|
|
Manufacturing
|
4.19%
|
O:
-0.22%
H:
0.0%
C:
-1.02%
PFE
|
News
|
$50.94
0.55%
-0.43%
|
|
Health Technology
|
4.47%
|
O:
-2.24%
H:
0.0%
C:
0.0%
AMGN
|
$245.43
0.79%
0.0%
|
|
Health Technology
|
3.15%
|
O:
-0.41%
H:
0.73%
C:
-0.54%
TAK
|
$13.85
-0.07%
0.0%
|
|
Health Technology
|
4.29%
|
O:
-0.04%
H:
0.0%
C:
0.0%
LLY
|
News
S
|
$323.0
1.69%
0.07%
|
|
Health Technology
|
11.15%
|
O:
-0.49%
H:
0.98%
C:
0.56%
research
system
companies
market
Breast Implant Market Forecast Report 2021: USD 437.17 Million Market Growth Opportunity by 2025| Technavio
Published:
2022-06-14
(Crawled : 07:00)
- prnewswire.com
ESTA
|
$56.43
-0.12%
-0.27%
|
|
Health Technology
|
1.46%
|
O:
-1.29%
H:
0.42%
C:
-0.24%
ABBV
|
$154.14
1.08%
-1.03%
|
|
Health Technology
|
9.4%
|
O:
-1.04%
H:
0.87%
C:
-1.31%
report
implant
growth
market
Global Cytotoxic Drugs Market Estimated to Reach $14,885.2 Million by 2028 and Grow at 1.2% CAGR in the 2021-2028 Timeframe [202-Pages] | Report by Research Dive
Published:
2022-06-13
(Crawled : 13:20)
- prnewswire.com
JNJ
|
News
|
$176.99
0.03%
-0.29%
|
|
Health Technology
|
3.06%
|
O:
-0.99%
H:
0.0%
C:
0.0%
ABBV
|
$154.14
1.08%
-1.03%
|
|
Health Technology
|
6.79%
|
O:
-2.38%
H:
0.0%
C:
0.0%
SNY
|
News
|
$52.67
1.02%
-0.32%
|
|
Health Technology
|
3.25%
|
O:
-1.69%
H:
0.0%
C:
0.0%
GSK
|
News
|
$43.77
0.97%
-0.87%
|
|
Health Technology
|
1.05%
|
O:
-0.52%
H:
0.0%
C:
0.0%
NVS
|
News
|
$84.77
0.71%
-0.64%
|
|
Health Technology
|
0.03%
|
O:
-1.86%
H:
0.0%
C:
0.0%
LLY
|
News
S
|
$323.0
1.69%
0.07%
|
|
Health Technology
|
7.68%
|
O:
-3.12%
H:
0.0%
C:
0.0%
GLAXF
|
News
|
$21.01
-4.46%
|
|
Health Technology
|
-3.73%
|
O:
1.53%
H:
0.0%
C:
-4.56%
research
report
market
AbbVie Announces Late-Breaking Results from Phase 2 Trial of Investigational Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory Large B-cell Lymphoma (LBCL) at the European Hematology Association (EHA) Annual Congress
Published:
2022-06-11
(Crawled : 16:20)
- prnewswire.com
ABBV
|
$154.14
1.08%
-1.03%
|
|
Health Technology
|
Email alert
Add to watchlist
cd20
duobody
trial
results
ABBVIE INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of AbbVie Inc. - ABBV
Published:
2022-06-11
(Crawled : 04:20)
- prnewswire.com
ABBV
|
$154.14
1.08%
-1.03%
|
|
Health Technology
|
Email alert
Add to watchlist
initiated
← Previous
1
2
3
4
5
6
7
8
9
…
23
24
Next →
USA Holiday (Independence Day) in 4 days
Your saved searches
Save your searches and get alerts when important news are released.
Mentioned Today
ACN
|
News
|
$279.81
-1.41%
-0.96%
|
|
Technology Services
ALTR
|
News
|
$51.79
1.05%
0.0%
|
|
Technology Services
ARQQ
|
News
|
$5.6
-0.18%
10.71%
|
|
Information
ATHE
|
News
|
$0.6406
-1.45%
-1.65%
|
|
Health Technology
BDX
|
News
4
|
$249.34
1.97%
0.0%
|
|
Health Technology
BNPQF
|
News
|
$48.11
-3.1%
|
|
Finance
BNPQY
|
News
|
$24.69
-1.2%
|
|
Finance and Insurance
BNPZY
|
News
|
$
0%
|
|
Finance and Insurance
BTC
|
News
|
$
0%
|
|
n/a
BTGOF
|
News
|
$2.35
2.17%
|
|
Communications
CAE
|
News
|
$24.13
-2.27%
0.0%
|
|
Commercial Services
CALT
|
News
|
$17.52
-1.21%
0.0%
|
|
Health Technology
CCC
|
News
|
$28.94
0%
|
|
Commercial Services
CDNA
|
News
|
$22.09
0.78%
0.0%
|
|
Health Technology
CGC
|
News
4
|
$3.5
-3.05%
-6.86%
|
|
Process Industries
CLVT
|
News
|
$14.13
0.71%
0.0%
|
|
Information
CONE
|
News
|
$90.25
0%
|
|
Finance
CRM
|
News
4
|
$170.61
-0.5%
-2.09%
|
|
Technology Services
DAO
|
News
|
$5.27
-4.87%
0.0%
|
|
Technology Services
ENS
|
News
|
$57.69
-1.94%
0.0%
|
|
Producer Manufacturing
ERIC
|
News
|
$7.64
-1.8%
1.57%
|
|
Electronic Technology
ESLT
|
News
|
$218.6
3.91%
0.64%
|
|
Electronic Technology
FDS
|
News
4
|
$383.1
1.89%
5.0%
|
|
Technology Services
FLNG
|
News
|
$27.21
-1.66%
2.76%
|
|
Energy Minerals
FNCTF
|
News
|
$11.8637
3.98%
|
|
Communications
FTRP
|
News
|
$0.85
-1.31%
|
|
Health Care and Social Assistan...
GBTC
|
News
|
$
0%
|
|
HIL
|
News
|
$1.69
3.05%
0.0%
|
|
Industrial Services
HYW
|
News
|
$6.75
-1.46%
0.0%
|
|
Finance and Insurance
INAPQ
|
News
|
$
0%
|
|
n/a
JCI
|
News
|
$48.68
0.5%
-0.04%
|
|
Producer Manufacturing
JNJ
|
News
|
$176.99
0.03%
-0.29%
|
|
Health Technology
KEQU
|
News
4
|
$14.0
0.36%
-1.79%
|
|
Producer Manufacturing
KHC
|
News
4
|
$37.98
0.66%
-0.24%
|
|
Consumer Non-Durables
MGNI
|
News
|
$9.44
-0.94%
-0.32%
|
|
Commercial Services
NTES
|
News
|
$92.52
-1.28%
0.84%
|
|
Technology Services
NVS
|
News
|
$84.77
0.71%
-0.64%
|
|
Health Technology
NVSEF
|
News
|
$84.85
1.0%
|
|
Health Technology
OKTA
|
News
4
|
$93.36
0.82%
0.0%
|
|
Technology Services
OSCR
|
News
|
$4.41
-3.08%
0.0%
|
|
PCRFF
|
News
|
$8.217
0.82%
|
|
n/a
PCRFY
|
News
|
$8.11
-0.61%
|
|
n/a
PEGA
|
News
|
$49.16
-0.51%
0.0%
|
|
Technology Services
POOL
|
News
|
$349.98
-0.88%
0.0%
|
|
Distribution Services
QSR
|
News
|
$49.61
1.1%
-0.4%
|
|
Consumer Services
RUBI
|
News
|
$
0%
|
|
Commercial Services
RYLPF
|
News
|
$21.116
-1.44%
|
|
Health Technology
SAP
|
News
|
$93.93
-1.61%
-5.46%
|
|
Technology Services
SAPGF
|
News
|
$93.64
-3.84%
|
|
Technology Services
STZ
|
News
|
$243.63
-0.77%
0.0%
|
|
Consumer Non-Durables
TDOC
|
News
|
$34.35
-2.08%
-2.48%
|
|
Health Services
TGH
|
News
|
$27.22
-2.05%
0.66%
|
|
Finance
UL
|
News
|
$45.56
0.51%
-0.83%
|
|
Consumer Non-Durables
UNLYF
|
News
|
$45.09
-1.56%
|
|
Consumer Non-Durables
VRCA
|
News
0 d
|
$2.17
-6.87%
-1.29%
|
|
Health Technology
WHR
|
News
|
$157.74
-2.04%
-0.22%
|
|
Consumer Durables